Why did EXOT choose Exosome Technology as our flagship frontier? 🧬
The numbers speak for themselves:
• Market Growth: Projected to grow from $380M in 2024 to $2.28B by 2030.
• CAGR: A remarkable 32.1% annual growth rate, outpacing most biotech sectors.
• Versatility: Transforming oncology, regenerative medicine, and diagnostics.
At EXOT, we don't just follow trends; we tokenize the most explosive assets in modern science.